CDH1 and neoplasm: Rather, our results suggest that the lack or low expression of E-cadherin in 4T1 and MTΔECad cells and in later stages of MMTV-PyMT tumor progression, and thus the invasive nature of the cancer cells, may serve as a molecular biomarker for an anti-metastatic activity of BI 853520.